메뉴 건너뛰기




Volumn 183, Issue 2, 2004, Pages 249-256

How thyroid tumors start and why it matters: Kinase mutants as targets for solid cancer pharmacotherapy

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINO 7 TERT BUTYL 5 (4 CHLOROPHENYL)PYRAZOLO[3,4 D]PYRIMIDINE; 4 AMINO 7 TERT BUTYL 5 (4 METHYLPHENYL)PYRAZOLO[3,4 D]PYRIMIDINE; CEP 701; CEP 751; IMATINIB; IMIDAZOLE DERIVATIVE; L 779450; ONCOPROTEIN; OXINDOLE; PROTEIN INHIBITOR; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE INHIBITOR; PYRIMIDINE DERIVATIVE; RADIOACTIVE IODINE; RAF PROTEIN; RP 1; SORAFENIB; UNCLASSIFIED DRUG; UREA DERIVATIVE; VANDETANIB;

EID: 9444277283     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/joe.1.05895     Document Type: Review
Times cited : (122)

References (56)
  • 2
    • 0029893933 scopus 로고    scopus 로고
    • A mutation at tyrosine 1062 in MEN2A-Ret and MEN2B-Ret impairs their transforming activity and association with shc adaptor proteins
    • Asai N, Murakami H, Iwashita T & Takahashi M 1996 A mutation at tyrosine 1062 in MEN2A-Ret and MEN2B-Ret impairs their transforming activity and association with shc adaptor proteins. Journal of Biological Chemistry 271 17644-17649.
    • (1996) Journal of Biological Chemistry , vol.271 , pp. 17644-17649
    • Asai, N.1    Murakami, H.2    Iwashita, T.3    Takahashi, M.4
  • 10
    • 4444273158 scopus 로고    scopus 로고
    • Disease associated mutations at valine 804 in the RET receptor tyrosine kinase confer resistance to selective kinase inhibitors
    • Carlomagno F, Guida T, Anaganti S, Vecchio G, Fusco A, Ryan AJ, Billaud M & Santoro M 2004 Disease associated mutations at valine 804 in the RET receptor tyrosine kinase confer resistance to selective kinase inhibitors. Oncogene 23 6056-6063.
    • (2004) Oncogene , vol.23 , pp. 6056-6063
    • Carlomagno, F.1    Guida, T.2    Anaganti, S.3    Vecchio, G.4    Fusco, A.5    Ryan, A.J.6    Billaud, M.7    Santoro, M.8
  • 12
    • 0035209830 scopus 로고    scopus 로고
    • Frequent RET rearrangements in thyroid papillary microcarcinoma detected by interphase fluorescence in situ hybridization
    • Corvi R, Martinez-Alfaro M, Harach HR, Zini M, Papotti M & Romeo G 2001 Frequent RET rearrangements in thyroid papillary microcarcinoma detected by interphase fluorescence in situ hybridization. Laboratory Investigation 81 1639-1645.
    • (2001) Laboratory Investigation , vol.81 , pp. 1639-1645
    • Corvi, R.1    Martinez-Alfaro, M.2    Harach, H.R.3    Zini, M.4    Papotti, M.5    Romeo, G.6
  • 13
    • 0037392444 scopus 로고    scopus 로고
    • Issues and progress with protein kinase inhibitors for cancer treatment
    • Dancey J & Sausville EA 2003 Issues and progress with protein kinase inhibitors for cancer treatment. Nature Reviews. Drug Discovery 2 296-313.
    • (2003) Nature Reviews. Drug Discovery , vol.2 , pp. 296-313
    • Dancey, J.1    Sausville, E.A.2
  • 17
    • 1842735328 scopus 로고    scopus 로고
    • Oncogenic B-Raf mutations: Crystal clear at last
    • Dhillon AS & Kolch W 2004 Oncogenic B-Raf mutations: crystal clear at last. Cancer Cell 5 303-304.
    • (2004) Cancer Cell , vol.5 , pp. 303-304
    • Dhillon, A.S.1    Kolch, W.2
  • 18
    • 0031924319 scopus 로고    scopus 로고
    • Shc and Enigma are both required for mitogenic signaling by Ret/ptc2
    • Durick K, Gill GN & Taylor SS 1998 Shc and Enigma are both required for mitogenic signaling by Ret/ptc2. Molecular and Cellular Biology 18 2298-2308.
    • (1998) Molecular and Cellular Biology , vol.18 , pp. 2298-2308
    • Durick, K.1    Gill, G.N.2    Taylor, S.S.3
  • 19
    • 0035810142 scopus 로고    scopus 로고
    • Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome
    • Druker BJ, Sawyers CL, Kantarjian H, Resta DJ, Reese SF, Ford JM, Capdeville R & Talpaz M 2001 Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome. New England Journal of Medicine 344 1038-1042.
    • (2001) New England Journal of Medicine , vol.344 , pp. 1038-1042
    • Druker, B.J.1    Sawyers, C.L.2    Kantarjian, H.3    Resta, D.J.4    Reese, S.F.5    Ford, J.M.6    Capdeville, R.7    Talpaz, M.8
  • 23
    • 0034254249 scopus 로고    scopus 로고
    • Inhibition of c-kit receptor tyrosine kinase activity by STI 571, a selective tyrosine kinase inhibitor
    • Heinrich MC, Griffith DJ, Druker BJ, Wait CL, Ott KA & Zigler AJ 2000 Inhibition of c-kit receptor tyrosine kinase activity by STI 571, a selective tyrosine kinase inhibitor. Blood 96 925-932.
    • (2000) Blood , vol.96 , pp. 925-932
    • Heinrich, M.C.1    Griffith, D.J.2    Druker, B.J.3    Wait, C.L.4    Ott, K.A.5    Zigler, A.J.6
  • 29
    • 4043110591 scopus 로고    scopus 로고
    • Experts call for smarter approach to targeted therapies
    • Katsnelson A 2004 Experts call for smarter approach to targeted therapies. Nature Medicine 10 764.
    • (2004) Nature Medicine , vol.10 , pp. 764
    • Katsnelson, A.1
  • 30
    • 0037379904 scopus 로고    scopus 로고
    • High prevalence of BRAF mutations in thyroid cancer: Genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma
    • Kimura ET, Nikiforova MN, Zhu Z, Knauf JA, Nikiforov YE & Fagin JA 2003 High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma. Cancer Research 63 1454-1457.
    • (2003) Cancer Research , vol.63 , pp. 1454-1457
    • Kimura, E.T.1    Nikiforova, M.N.2    Zhu, Z.3    Knauf, J.A.4    Nikiforov, Y.E.5    Fagin, J.A.6
  • 31
    • 0042303810 scopus 로고    scopus 로고
    • RET/PTC-induced dedifferentiation of thyroid cells is mediated through Y1062 signaling through SHC-RAS-MAP kinase
    • Knauf JA, Kuroda H, Basu S & Fagin JA 2003 RET/PTC-induced dedifferentiation of thyroid cells is mediated through Y1062 signaling through SHC-RAS-MAP kinase. Oncogene 22 4406-4412.
    • (2003) Oncogene , vol.22 , pp. 4406-4412
    • Knauf, J.A.1    Kuroda, H.2    Basu, S.3    Fagin, J.A.4
  • 35
    • 0034967978 scopus 로고    scopus 로고
    • Docking protein FRS2 links the protein tyrosine kinase RET and its oncogenic forms with the mitogen-activated protein kinase signaling cascade
    • Melillo RM, Santoro M, Ong SH, Billaud M, Fusco A, Hadari YR, Schlessinger J & Lax I 2001 Docking protein FRS2 links the protein tyrosine kinase RET and its oncogenic forms with the mitogen-activated protein kinase signaling cascade. Molecular and Cellular Biology 21 4177-4187.
    • (2001) Molecular and Cellular Biology , vol.21 , pp. 4177-4187
    • Melillo, R.M.1    Santoro, M.2    Ong, S.H.3    Billaud, M.4    Fusco, A.5    Hadari, Y.R.6    Schlessinger, J.7    Lax, I.8
  • 36
    • 0030881411 scopus 로고    scopus 로고
    • Continued expression of a tissue specific activated oncogene in the early steps of radiation-induced human thyroid carcinogenesis
    • Mizuno T, Kyoizumi S, Suzuki T, Iwamoto KS & Seyama T 1997 Continued expression of a tissue specific activated oncogene in the early steps of radiation-induced human thyroid carcinogenesis. Oncogene 15 1455-1460.
    • (1997) Oncogene , vol.15 , pp. 1455-1460
    • Mizuno, T.1    Kyoizumi, S.2    Suzuki, T.3    Iwamoto, K.S.4    Seyama, T.5
  • 37
    • 0028862490 scopus 로고
    • Characterization of RET proto-oncogene 3′ splicing variants and polyadenylation sites: A novel C-terminus for RET
    • Myers SM, Eng C, Ponder BA & Mulligan LM 1995 Characterization of RET proto-oncogene 3′ splicing variants and polyadenylation sites: a novel C-terminus for RET. Oncogene 11 2039-2045.
    • (1995) Oncogene , vol.11 , pp. 2039-2045
    • Myers, S.M.1    Eng, C.2    Ponder, B.A.3    Mulligan, L.M.4
  • 39
    • 0033524002 scopus 로고    scopus 로고
    • Chromosomal breakpoint positions suggest a direct role for radiation in inducing illegitimate recombination between the ELE1 and RET genes in radiation-induced thyroid carcinomas
    • Nikiforov YE, Koshoffer A, Nikiforova M, Stringer J & Fagin JA 1999 Chromosomal breakpoint positions suggest a direct role for radiation in inducing illegitimate recombination between the ELE1 and RET genes in radiation-induced thyroid carcinomas. Oncogene 18 6330-6334.
    • (1999) Oncogene , vol.18 , pp. 6330-6334
    • Nikiforov, Y.E.1    Koshoffer, A.2    Nikiforova, M.3    Stringer, J.4    Fagin, J.A.5
  • 40
  • 42
    • 0034762203 scopus 로고    scopus 로고
    • The Raf/MEK/ERK pathway: New concepts of activation
    • Peyssonnaux C & Eychene A 2001 The Raf/MEK/ERK pathway: new concepts of activation. Biology of the Cell 93 53-62.
    • (2001) Biology of the Cell , vol.93 , pp. 53-62
    • Peyssonnaux, C.1    Eychene, A.2
  • 47
    • 0034603172 scopus 로고    scopus 로고
    • Transforming ability of MEN2A-RET requires activation of the phosphatidylinositol 3-kinase/AKT signaling pathway
    • Segouffin-Cariou C & Billaud M 2000 Transforming ability of MEN2A-RET requires activation of the phosphatidylinositol 3-kinase/AKT signaling pathway. Journal of Biological Chemistry 275 3568-3576.
    • (2000) Journal of Biological Chemistry , vol.275 , pp. 3568-3576
    • Segouffin-Cariou, C.1    Billaud, M.2
  • 48
    • 0001686739 scopus 로고    scopus 로고
    • Multiple BCR-ABL kinase domain mutations confer polyclonal resistance to the tyrosine kinase inhibitor imatinib (STI571) in chronic phase and blast crisis chronic myeloid leukemia
    • Shah NP, Nicoll JM, Nagar B, Gorre ME, Paquette RL, Kuriyan J & Sawyers CL 2002 Multiple BCR-ABL kinase domain mutations confer polyclonal resistance to the tyrosine kinase inhibitor imatinib (STI571) in chronic phase and blast crisis chronic myeloid leukemia. Cancer Cell 2 117-125.
    • (2002) Cancer Cell , vol.2 , pp. 117-125
    • Shah, N.P.1    Nicoll, J.M.2    Nagar, B.3    Gorre, M.E.4    Paquette, R.L.5    Kuriyan, J.6    Sawyers, C.L.7
  • 56
    • 0041589377 scopus 로고    scopus 로고
    • High prevalence of BRAF gene mutation in papillary thyroid carcinomas and thyroid tumor cell lines
    • Xu X, Quiros RM, Gattuso P, Ain KB & Prinz RA 2003 High prevalence of BRAF gene mutation in papillary thyroid carcinomas and thyroid tumor cell lines. Cancer Research 63 4561-4567.
    • (2003) Cancer Research , vol.63 , pp. 4561-4567
    • Xu, X.1    Quiros, R.M.2    Gattuso, P.3    Ain, K.B.4    Prinz, R.A.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.